Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
Friedrich-Alexander-Universität Erlangen-Nürnberg · University of Utah · +3 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
715
total citations
- FWCI
- 31.26
- Percentile
- 100%
- References
- 43
Citations per year
Authors
9Topics & keywords
Topics
Keywords
- Medicine
- Infliximab
- Placebo
- Psoriasis
- Psoriatic arthritis
- Internal medicine
- Dactylitis
- Enthesopathy
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.